These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5164592)

  • 21. Effects and use of a modified live Anaplasma marginale vaccine in beef heifers in California.
    Henry ET; Norman BB; Fly DE; Wichmann RW; York SM
    J Am Vet Med Assoc; 1983 Jul; 183(1):66-9. PubMed ID: 6874525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premunization with an attenuated Anaplasma marginale.
    Kuttler KL; Zaraza H
    Proc Annu Meet U S Anim Health Assoc; 1969; 73():104-12. PubMed ID: 5278167
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of antigenic differences that discriminate between cattle vaccinated with Anaplasma centrale and cattle naturally infected with Anaplasma marginale.
    Molloy JB; Bock RE; Templeton JM; Bruyeres AG; Bowles PM; Blight GW; Jorgensen WK
    Int J Parasitol; 2001 Feb; 31(2):179-86. PubMed ID: 11239938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory and field trials with an attenuated Anaplasma marginale vaccine.
    Welter CJ; Ristic M
    Proc Annu Meet U S Anim Health Assoc; 1969; 73():122-30. PubMed ID: 5278170
    [No Abstract]   [Full Text] [Related]  

  • 26. Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.
    Kenneil R; Shkap V; Leibovich B; Zweygarth E; Pfister K; Ribeiro MF; Passos LM
    Transbound Emerg Dis; 2013 Nov; 60 Suppl 2():97-104. PubMed ID: 24589108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia.
    Vizcaino O; Carson CA; Lee AJ; Ristic M
    Am J Vet Res; 1978 Feb; 39(2):229-33. PubMed ID: 629456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epizootiologic studies of anaplasmosis in Oregon mule deer.
    Peterson KJ; Kistner TP; Davis HE
    J Wildl Dis; 1973 Oct; 9(4):314-9. PubMed ID: 4784318
    [No Abstract]   [Full Text] [Related]  

  • 29. Sheep-adapted Anaplasma marginale maintains virulence for cattle.
    Jorgensen WK; Bock RE; De Vos AJ; Shiels IA
    Aust Vet J; 1993 May; 70(5):192-3. PubMed ID: 8343094
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duration of carrier state following vaccination with live Anaplasma centrale.
    Krigel Y; Pipano E; Shkap V
    Trop Anim Health Prod; 1992 Nov; 24(4):209-10. PubMed ID: 1305342
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
    PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the Anaplasma centralevaccine strain and specific differentiation from Anaplasma marginale in vaccinated and infected cattle.
    Shkap V; Molad T; Fish L; Palmer GH
    Parasitol Res; 2002 Jun; 88(6):546-52. PubMed ID: 12107477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic comparisons of 4 Anaplasma isolates as measured by the complement-fixation test.
    Kuttler KL; Winward LD
    Vet Microbiol; 1984 Apr; 9(2):181-6. PubMed ID: 6203210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen beads: a novel approach for the delivery of a soluble Anaplasma immunogen.
    James MA; Coronado A; Melendez RD; Ristic M
    Am J Vet Res; 1984 Oct; 45(10):2123-5. PubMed ID: 6388435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of tetracycline and Babesia culture supernatant as prophylactics for moderating reactions in cattle to live Babesia and Anaplasma vaccines.
    Jorgensen WK; Bock RE; Kingston TG; de Vos AJ; Waldron SJ
    Aust Vet J; 1993 Jan; 70(1):35-6. PubMed ID: 8460988
    [No Abstract]   [Full Text] [Related]  

  • 40. A proposed method of premunizing cattle with minimum inocula of Anaplasma marginale.
    Franklin TE; Huff JW
    Res Vet Sci; 1967 Oct; 8(4):415-8. PubMed ID: 6070724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.